No Data
Investing in Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Five Years Ago Would Have Delivered You a 150% Gain
TJ DaRenTang (600329.SH): Currently holds a 43.35% equity stake in Tianyao Taiping Pharmaceutical Co., Ltd.
On December 26, Gelonghui reported that TJ DaRenTang (600329.SH) announced that the company will price the entire equity of its wholly-owned subsidiary Tianjin Zhongxin Pharmaceutical Co., Ltd. and inject it as a capital increase into the wholly-owned subsidiary of its controlling shareholder Tianjin Pharmaceutical Group Co., Ltd., JinYao Taiping Pharmaceutical Co., Ltd., and signed the "Capital Increase Agreement between JinYao DaRenTang Group Co., Ltd. and JinYao Taiping Pharmaceutical Co., Ltd." Recently, JinYao Taiping Pharmaceutical Co., Ltd. and Tianjin Zhongxin Pharmaceutical Co., Ltd. have completed the business change registration procedures. Therefore, this Trade has been completed, and the company holds 43.35% of JinYao Taiping Pharmaceutical Co., Ltd.
Take Care Before Diving Into The Deep End On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)
Tj Darentang USD: Wang Lei succeeds Zhang Mingrui as chairman, the company's development global strategy "will not change" | Express announcement
① Zhang Mingrui has applied to resign from the positions of tj darentang usd chairman, director, and chairman of the Global Strategy Committee due to work-related reasons. ② Wang Lei, the general manager of the company, will take over as chairman, with company officials stating that the enterprise's development strategy "will not change".
Express News | Tianjin Pharmaceutical Da Ren Tang Group Corp - Zhang Mingrui Resigns as Chairman
tj darentang (600329.SH): Elected director Wang Lei as the chairman of the company.
Grainbull November 26th | tj darentang usd (600329.SH) announced that they have received Ms. Zhang Mingrui's written resignation. Due to job changes, Ms. Zhang Mingrui has applied to resign from the positions of company chairman, director, and chairman of the strategic committee. After the resignation, Ms. Zhang Mingrui will no longer hold any position in the company. After the company board of directors' nomination and the nomination committee's review, the meeting approved the proposal to "elect Ms. Wang Lei as the company's chairman." According to the company's articles of association, the company's legal representative will be changed to Ms. Wang Lei.
Could The Market Be Wrong About Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) Given Its Attractive Financial Prospects?
